American Vietnamese Biotech

American Vietnamese Biotech EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of American Vietnamese Biotech (AMV.VN) as of Oct 18, 2026 is -1.87 B VND. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 32.54 B VND — a change of -105.75% (lower).

EBITDA

-1.87 BVND

YoY

-105.75%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of American Vietnamese Biotech is 2024 -1.87 B VND. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of American Vietnamese Biotech was 2023 32.54 B VND. It decreases by -105.75% lower compared to the previous year.

The American Vietnamese Biotech EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2017
39.98 B VND
Jan 1, 2018
222.64 B VND
Jan 1, 2019
226.98 B VND
Jan 1, 2020
69.93 B VND
Jan 1, 2021
96.32 B VND
Jan 1, 2022
67.46 B VND
Jan 1, 2023
32.54 B VND
Jan 1, 2024
-1.87 B VND
The American Vietnamese Biotech EBITDA history
YEAREBITDAYoY
-1.87 BVND-105.75%
32.54 BVND-51.77%
67.46 BVND-29.96%
96.32 BVND+37.74%
69.93 BVND-69.19%
226.98 BVND+1.95%
222.64 BVND+456.96%
39.98 BVND+2,090.87%
1.82 BVND+189.17%
630.99 MVND-120.30%
-3.11 BVND—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

American Vietnamese Biotech Stock analysis

What does American Vietnamese Biotech do? American Vietnamese Biotech Inc, headquartered in Ho Chi Minh City, Vietnam, operates in the Health Care sector. The company manufactures and distributes high-tech medical diagnostics devices, equipment, medicines, vaccines, biological products, rapid diagnostic tests, and ELISA kits. It also trades medical equipment and tools, produces cosmetic, soap, detergent, and cleaning products, and engages in real estate trading, financial investments, and plastic product manufacturing. Listed on December 20, 2009, the company had one wholly owned subsidiary as of 2012. American Vietnamese Biotech is one of the most popular companies on Eulerpool.

Frequently Asked Questions about American Vietnamese Biotech stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of American Vietnamese Biotech is -1.87 B VND in 2024.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of American Vietnamese Biotech changed from 32.54 B VND to -1.87 B VND, representing a -105.75% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) American Vietnamese Biotech since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s VND is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s American Vietnamese Biotech historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — American Vietnamese Biotech

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — American Vietnamese Biotech